Article Details
Retrieved on: 2024-09-25 19:30:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Kiromic BioPharma has received a unanimous recommendation to move ahead dose expansion from the safety monitoring committee (SMC) for the phase 1/2 ...
Article found on: www.cgtlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here